Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.

The abstract of the research article discusses a study that aimed to investigate the roles of certain substances, specifically 5-hydroxytryptamine (5-HT), thromboxane A2 (TxA2), and platelet-activating factor (PAF), in causing restricted blood flow in horses’ extremities due to the effects of endotoxins.

Research Methodology

• The study was conducted on six healthy adult Thoroughbred horses.
• These horses were treated with various substances and their reactions were measured. These substances included an IV administration of saline solution as a control; GR55562, an antagonist of 5-HT 1B/D; aspirin, an anti-inflammatory drug; and WEB2086, a PAF antagonist. These drugs were sometimes used in combination.
• The method of measuring the reactions included Doppler ultrasonography to measure blood flow in the horses’ digits, temperature measurements of the hoof wall and coronary band surface, and blood samples to determine plasma 5-HT and TxA2 concentrations.

Results and Conclusions

• The antagonist GR55562 effectively eliminated the restricted blood flow in the horses’ digits that was caused by the infusion of tryptamine (a byproduct of 5-HT).
• Neither the PAF antagonist WEB2086 nor GR55562 had any effect on the changes in digit perfusion or plasma mediator concentrations caused by the infusion of lipopolysaccharide (LPS), a type of endotoxin.
• Aspirin significantly reduced the increase in TxA2 concentration and digit hypoperfusion caused by LPS, whether it was administered two hours or four days in advance. It also demonstrated greater effects in reducing LPS-induced hypothermia when combined with GR55562.
• Based on these findings, the researchers concluded that TxA2 and 5-HT play significant roles in mediating LPS-induced digit hypoperfusion in horses. Meanwhile, PAF does not seem to have a role in the release of 5-HT or TxA2 or in the hypoperfusion.